1. ChemInform Abstract: Antiphospholipid Antibody Profiling — Time for a New Technical Approach?. Issue 12 (14th March 2013) Authors: Roggenbuck, Dirk; Egerer, Karl; von Landenberg, Philipp; Hiemann, Rico; Feist, Eugen; Burmester, Gerd‐Ruediger; Doerner, Thomas Journal: ChemInform Issue: Volume 44:Issue 12(2013) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. (27th November 2021) Authors: Zorn-Pauly, Lydia; von Stuckrad, Anne Sae Lim; Klotsche, Jens; Rose, Thomas; Kallinich, Tilmann; Enghard, Philipp; Ostendorf, Lennard; Burns, Marie; Doerner, Thomas; Meisel, Christian; Schneider, Udo; Unterwalder, Nadine; Burmester, Gerd; Hiepe, Falk; Alexander, Tobias; Biesen, Robert Journal: Rheumatology Issue: Volume 61:Number 8(2022) Page Start: 3396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. Issue 3 (13th November 2020) Authors: Kerschbaumer, Andreas; Smolen, Josef S; Nash, Peter; Doerner, Thomas; Dougados, Maxime; Fleischmann, Roy; Geissler, Klaus; McInnes, Iain B; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin; de Wit, Maarten; Boehncke, Wolf-Henning; Falzon, Louise; van der Heijde, Desirée Journal: RMD open Issue: Volume 6:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗